Severe acute respiratory syndrome coronavirus 2 variants-Possibility of universal vaccine design: A review.

Yoon, Eunhye; Kim, Dahyun; Jeon, Hyeeun; Kwon, Yejin; Jang, Yejin; Kim, Sulhee; Hwang, Kwang Yeon

Yoon, Eunhye; Kim, Dahyun; Jeon, Hyeeun; Kwon, Yejin; Jang, Yejin; Kim, Sulhee; Hwang, Kwang Yeon.

Afiliación

Yoon E; Division of Biotechnology, College of Life Sciences and Biotechnology, Seoul 02841, South Korea.
Kim D; Division of Biotechnology, College of Life Sciences and Biotechnology, Seoul 02841, South Korea.
Jeon H; Division of Biotechnology, College of Life Sciences and Biotechnology, Seoul 02841, South Korea.
Kwon Y; Division of Biotechnology, College of Life Sciences and Biotechnology, Seoul 02841, South Korea.
Jang Y; Division of Biotechnology, College of Life Sciences and Biotechnology, Seoul 02841, South Korea.
Kim S; Division of Biotechnology, College of Life Sciences and Biotechnology, Seoul 02841, South Korea.
Hwang KY; Institute of Bioresource, Korea University, Seoul 02841, South Korea.

Comput Struct Biotechnol J ; 20: 3533-3544, 2022.

Article en En | MEDLINE | ID: mdl-35765543

Palabras clave

ACE2, angiotensin-converting enzyme 2; Antigen; COVID-19; COVID-19, coronavirus disease 2019; Coronavirus; FDA, Food and Drug Administration; FP, fusion peptide; HE, hemagglutinin-esterase; HIV, human immunodeficiency virus; HR1, heptad repeat 1; HR2, heptad repeat 2; Oral drug; RBD, receptor binding domain; Receptor-binding domain; S1-CTD, S1 C-terminal domain; S1-NTD, S1 N-terminal domain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TMPRSS2, transmembrane protease serine 2; Universal vaccine; mAbs, monoclonal antibodies

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Comput Struct Biotechnol J Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Comput Struct Biotechnol J Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur